Civic Intelligence

Grace Science Foundation

990 • Fiscal year 2017 • EIN 46-5727883

Jan 01, 2017 to Dec 31, 2017 • Filed on May 11, 2018

Organization ProfileWWW.GRACESCIENCE.ORG
235 Kansas Street Suite 200San Francisco, CA 94103

(415) 255-7666

Siviq Scores

Scores are not available for this record yet.

Balance Sheet

Assets

Up

$2,109,224

Up $773,093 (+58%) from 2016

Net Assets

Up

$2,092,724

Up $756,593 (+57%) from 2016

Liabilities

Up

$16,500

Up $16,500 from 2016

Revenue And Expenses

Revenue

Up

$1,677,107

Up $1,076,983 (+179%) from 2016

Expenses

Up

$920,514

Up $50,707 (+5.8%) from 2016

Net Income

Up

$756,593

Up $1,026,276 (+381%) from 2016

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$4.0M$3.0M$2.0M$1.0M$0Assets 2014: $603,778Liabilities 2014: $0Net Assets 2014: $603,7782014Assets 2015: $1,605,814Liabilities 2015: $0Net Assets 2015: $1,605,8142015Assets 2016: $1,336,131Liabilities 2016: $0Net Assets 2016: $1,336,1312016Assets 2017: $2,109,224Liabilities 2017: $16,500Net Assets 2017: $2,092,7242017Assets 2018: $2,196,374Liabilities 2018: $0Net Assets 2018: $2,196,3742018Assets 2019: $2,889,615Liabilities 2019: $2,201Net Assets 2019: $2,887,4142019Assets 2020: $2,884,506Liabilities 2020: $386Net Assets 2020: $2,884,1202020Assets 2021: $3,128,030Liabilities 2021: $29,929Net Assets 2021: $3,098,1012021Assets 2022: $3,183,591Liabilities 2022: $51,224Net Assets 2022: $3,132,3672022Assets 2023: $2,790,274Liabilities 2023: $42,997Net Assets 2023: $2,747,2772023Assets 2024: $2,224,370Liabilities 2024: $1,004Net Assets 2024: $2,223,3662024

Highlighted filing

2017

Assets$2,109,224
Liabilities$16,500
Net Assets$2,092,724
Open 2017 Filing

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$2.0M$1.0M$0-$1.0MRevenue 2014: $664,490Expenses 2014: $60,712Net Income 2014: $603,7782014Revenue 2015: $1,560,381Expenses 2015: $558,345Net Income 2015: $1,002,0362015Revenue 2016: $600,124Expenses 2016: $869,807Net Income 2016: -$269,6832016Revenue 2017: $1,677,107Expenses 2017: $920,514Net Income 2017: $756,5932017Revenue 2018: $1,199,988Expenses 2018: $1,074,064Net Income 2018: $125,9242018Revenue 2019: $1,561,302Expenses 2019: $839,395Net Income 2019: $721,9072019Revenue 2020: $1,454,180Expenses 2020: $1,452,901Net Income 2020: $1,2792020Revenue 2021: $1,327,113Expenses 2021: $1,113,132Net Income 2021: $213,9812021Revenue 2022: $1,236,228Expenses 2022: $1,218,482Net Income 2022: $17,7462022Revenue 2023: $826,626Expenses 2023: $1,289,174Net Income 2023: -$462,5482023Revenue 2024: $943,011Expenses 2024: $1,519,386Net Income 2024: -$576,3752024

Highlighted filing

2017

Revenue$1,677,107
Expenses$920,514
Net Income$756,593
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
May 11, 2018
Return Version
2017v2.2
Gross Receipts
$1,677,107
Mission and Program Overview

Mission

The mission of the foundation is to support and fund the development of life-saving treatment for patients that are deficient in the n-glycanese enzyme and those suffering from related genetic diseases. The activities of the foundation will involve providing grant funding to hospitals and medical research facilities which are conducting medical research in various fields relating to the search for understanding and treatment of this condition, and fostering collaboration between academia, research institutions, hospitals, private companies, and governmental agencies.

The mission of the foundation is to support and fund the development of life-saving treatment for patients that are deficient in the n-glycanese enzyme and those suffering from related genetic diseases.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$1,336,006$2,109,224▲ $773,218
Rtn Earn Endowment Incm Other Fnds$1,336,131$2,092,724▲ $756,593
Accounts Receivable$125$0▼ $125
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$1,336,131$2,109,224▲ $773,093
Liabilities
Grants Payable$0$16,500▲ $16,500
Total Liabilities$0$16,500▲ $16,500
Net Assets / Fund Balance
Total Net Assets Fund Balance$1,336,131$2,092,724▲ $756,593
Total Liabilities and Net Assets / Fund Balance$1,336,131$2,109,224▲ $773,093
Compensation and Service Providers

Board Members and Trustees

NameTitle
Matthew WilseyPresident
Chelsea ClintonDirector
Elle StephensDirector
J Taylor CrandallDirector
Pete BrigerDirector
Egon DurbanChief Financial Officer
Ken DrazanSecretary
Revenue and Support

Revenue Composition

Contributions and Grants
$1,651,481
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$25,626
All Other Contributions
$1,651,481
Change in Net Assets
$756,593
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$696,567
Other Expenses$223,947
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$659,067--$659,067
Conferences and Meetings$77,567$18-$77,585
Fees for Services Other-$65,750-$65,750
Foreign Grants$37,500--$37,500
Travel$26,352$38-$26,390
Fees for Services Legal-$17,525-$17,525
Office Expenses$1,985$7,305-$9,290
Fees for Services Accounting-$4,250-$4,250
Insurance$116$955-$1,071
Advertising-$800-$800
Other Expenses-$105-$105
Total Functional Expenses$802,587$117,927$0$920,514
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Stanford UniversityPalo Alto, CA501(c)(3)NGLY1 WORK IN CAROLYN BERTOZZI'S LAB AND LARS STEINMETZ LAB$350,000
Massachusetts General HospitalBoston, MA501(c)(3)NGLY1 WORK IN GARY RUVKUN'S LAB$100,000
Perlara PbcS San Francisco, CA501(c)(3)Assay Development & Compound Screening$90,000
Baylor College of MedicineHouston, TX501(c)(3)NGLY1 WORK IN HAMED JAFAR-NEJAD'S LAB$65,000
Virginia Commonwealth UniversityBox Richmond, VA501(c)(3)NGLY1 WORK IN SENTHIL RADHAKRISHNAN'S LAB$37,567
Stanford HealthcareStanford, CA-Fibroblast Collection$16,500

International Summary

Offices
0
Employees
0
Spending
$0

International Compliance

Foreign grant records maintained
No
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

“The president of the foundation has immaterial ownership interest, in the investments of fortress and silver lake, which are managed by two of the directors.”

Form 990, Part VI, Section A, Line 7A

“The president of the foundation has authority to elect one or more members of the governing body.”

Form 990, Part VI, Section A, Line 8B

“The foundation does not have any committees.”

Form 990, Part VI, Section B, Line 11B

“Prior to filing from 990, the foundation's president will review the form.”

Form 990, Part VI, Section B, Line 12C

“New board members are required to complete a conflicts of interest policy and self report any changes that may present a conflict.”

Form 990, Part VI, Section C, Line 18

“AVAILABLE UPON REQUEST.”

Form 990, Part VI, Section C, Line 19

“AVAILABLE UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Grace Science Foundation
EIN
46-5727883
Phone
4152557666
Address
235 KANSAS STREET SUITE 200, SAN FRANCISCO, CA 94103

Signing Officer

Name
Matthew R Wilsey
Title
President
Phone
4152557666
Signed
2018-05-11
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Matthew R Wilsey
Formed
2014
Legal Domicile
CA
Voting Board Members
7
Independent Board Members
7
Employees
0
Volunteers
5

Preparer

Firm
Oum & Co Llp
Address
601 CALIFORNIA STREET SUITE 1800, SAN FRANCISCO, CA 94108
Preparer
Bradford Weisert
Phone
4154343744
Raw XML AppendixShowing 400 of 446 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsReceivableGrp/BOYAmt0125
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE MISSION OF THE FOUNDATION IS TO SUPPORT AND FUND THE DEVELOPMENT OF LIFE-SAVING TREATMENT FOR PATIENTS THAT ARE DEFICIENT IN THE N-GLYCANESE ENZYME AND THOSE SUFFERING FROM RELATED GENETIC DISEASES.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt0800
IRS990/AdvertisingGrp/TotalAmt0800
IRS990/AllOtherContributionsAmt01651481
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0GRACE SCIENCE FOUNDATION
IRS990/BooksInCareOfDetail/PhoneNum04152557666
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0235 KANSAS STREET SUITE 200
IRS990/BooksInCareOfDetail/USAddress/CityNm0SAN FRANCISCO
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094103
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt01336006
IRS990/CashNonInterestBearingGrp/EOYAmt02109224
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt018
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt077567
IRS990/ConferencesMeetingsGrp/TotalAmt077585
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01651481
IRS990/CYGrantsAndSimilarPaidAmt0696567
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0223947
IRS990/CYOtherRevenueAmt025626
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0756593
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0920514
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01677107
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0STANFORD UNIVERSITY (STEINMETZ LAB) - TEAM USED A SYSTEM GENETICS APPROACH TO INVESTIGATE THE MECHANISMS BEHIND NGLY1 DEFICIENCY. THEY DEVELOPED AND LAUNCHED HIGH THROUGHPUT SCREENING FOR GENES AND COMPOUNDS THAT INFLUENCE NGLY1 DEFICIENT CELLS, DEFINED THERAPEUTIC AND MOLECULAR INTERVENTION POINTS, AND CHARACTERIZED NGLY1 DEFICIENT CELLS ON A MOLECULAR BASIS. TEAM IS NOW WORKING TO DISSEMINATE THE DATA ALREADY GATHERED AND EXPANDING THE FINDINGS THEY HAVE ALREADY MADE.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0267670
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt04250
IRS990/FeesForServicesAccountingGrp/TotalAmt04250
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt017525
IRS990/FeesForServicesLegalGrp/TotalAmt017525
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt065750
IRS990/FeesForServicesOtherGrp/TotalAmt065750
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt037500
IRS990/ForeignGrantsGrp/TotalAmt037500
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt020.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/PersonNm0MATTHEW WILSEY
IRS990/Form990PartVIISectionAGrp/PersonNm1EGON DURBAN
IRS990/Form990PartVIISectionAGrp/PersonNm2KEN DRAZAN
IRS990/Form990PartVIISectionAGrp/PersonNm3PETE BRIGER
IRS990/Form990PartVIISectionAGrp/PersonNm4CHELSEA CLINTON
IRS990/Form990PartVIISectionAGrp/PersonNm5J TAYLOR CRANDALL
IRS990/Form990PartVIISectionAGrp/PersonNm6ELLE STEPHENS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1CHIEF FINANCIAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd00
IRS990/FormationYr02014
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt07
IRS990/GrantAmt0250000
IRS990/GrantsPayableGrp/BOYAmt00
IRS990/GrantsPayableGrp/EOYAmt016500
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0659067
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0659067
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt01677107
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt07
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt0955
IRS990/InsuranceGrp/ProgramServicesAmt0116
IRS990/InsuranceGrp/TotalAmt01071
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt08
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd00
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE MISSION OF THE FOUNDATION IS TO SUPPORT AND FUND THE DEVELOPMENT OF LIFE-SAVING TREATMENT FOR PATIENTS THAT ARE DEFICIENT IN THE N-GLYCANESE ENZYME AND THOSE SUFFERING FROM RELATED GENETIC DISEASES. THE ACTIVITIES OF THE FOUNDATION WILL INVOLVE PROVIDING GRANT FUNDING TO HOSPITALS AND MEDICAL RESEARCH FACILITIES WHICH ARE CONDUCTING MEDICAL RESEARCH IN VARIOUS FIELDS RELATING TO THE SEARCH FOR UNDERSTANDING AND TREATMENT OF THIS CONDITION, AND FOSTERING COLLABORATION BETWEEN ACADEMIA, RESEARCH INSTITUTIONS, HOSPITALS, PRIVATE COMPANIES, AND GOVERNMENTAL AGENCIES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt01336131
IRS990/NetAssetsOrFundBalancesEOYAmt02092724
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt07305
IRS990/OfficeExpensesGrp/ProgramServicesAmt01985
IRS990/OfficeExpensesGrp/TotalAmt09290
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0OTHER FEES (BANK, CREDI
IRS990/OtherExpensesGrp/Desc1MISCELLANEOUS EXPENSES
IRS990/OtherExpensesGrp/Desc2FILING FEES
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt020129
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt11052
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt2105
IRS990/OtherExpensesGrp/TotalAmt020129
IRS990/OtherExpensesGrp/TotalAmt11052
IRS990/OtherExpensesGrp/TotalAmt2105
IRS990/OtherRevenueMiscGrp/BusinessCd0541900
IRS990/OtherRevenueMiscGrp/Desc0RETURN OF GRANT MONEY
IRS990/OtherRevenueMiscGrp/ExclusionAmt025626
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt025626
IRS990/OtherRevenueTotalAmt025626
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0MATTHEW R WILSEY
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0MASSACHUSETTS GENERAL HOSPITAL - TEAM COMPLETED LARGE-SCALE GENETIC SCREENS FOR MODIFIERS OF PROTEASOME DYSFUNCTION IN PNG-1/NGLY1 DEFICIENT C. ELEGANS. THESE SCREENS IDENTIFIED CONSERVED GENES THAT ARE POSSIBLE THERAPEUTIC TARGETS FOR TREATMENT OF NGLY1 DEFICIENCY AND LIKELY OTHER DISEASES OF PROTEOTOXIC DISTRESS. THE TEAM ALSO CONTINUED EXPERIMENTS AIMED AT UNDERSTANDING PNG-1 SUPPRESSORS' MECHANISM(S) OF ACTION. IN ADDITION, THE LAB GENERATED TRANSGENIC ANIMALS THAT EXPRESS AN ENGINEERED SKN-1A THAT BYPASSES THE REQUIREMENT FOR DEGLYCOSYLATION BY PNG-1. THE ANALYSIS OF THESE ANIMALS PROVIDES NEW EVIDENCE THAT DEFECTS RESULTING FROM PNG-1 / NGLY1 DEFICIENCY MAY BE ENTIRELY EXPLAINED BY FAILURE TO ACTIVATE SKN-1A/NRF1.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0117670
IRS990/ProgSrvcAccomActy2Grp/GrantAmt0100000
IRS990/ProgSrvcAccomActy3Grp/Desc0STANFORD UNIVERSITY (BERTOZZI LAB) - TEAM UNCOVERED AN INTERESTING PHENOTYPE OF NGLY1 DEFICIENT STEM CELLS THAT COULD BE AMENABLE TO HIGH-THROUGHPUT SCREENS FOR CORRECTIVE THERAPIES (BOTH SMALL MOLECULE AND GENE-BASED APPROACHES). THIS PHENOMENON MAY EXPLAIN VARIOUS HUMAN PATHOLOGIES OF TISSUES DERIVED FROM NEURAL CREST. IN ADDITION, TEAM MADE PROGRESS SCREENING SMALL MOLECULES FOR COMPENSATION OF DEFECTS IN NRF1-MEDIATED CYTOPROTECTION. TEAM COMPLETED A FINAL SET OF EXPERIMENTS IN ZEBRAFISH NGLY1 MODELS TO DETERMINE WHETHER THERE WERE FUNCTIONAL PHENOTYPES WORTH PURSUING IN AN EFFORT TO BETTER UNDERSTAND THE HUMAN DISEASE. TEAM CONCLUDED THAT THIS MODEL SHOULD NOT BE PRIORITIZED (AT LEAST NOT IN THIS LAB). FINALLY, THE BERTOZZI LAB DEVELOPED A SYSTEM FOR NGLY1-ASSOCIATED PROTEINS (SUBSTRATES) IN CELLS. THIS PLATFORM SHOULD BE USEFUL FOR IDENTIFYING NGLY1 SUBSTRATES IN AN UNBIASED MANNER.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0117670
IRS990/ProgSrvcAccomActy3Grp/GrantAmt0100000
IRS990/ProgSrvcAccomActyOtherGrp/Desc0PERLARA, PBC - TEAM ESTABLISHED HIGH THROUGHPUT SCREENING (HTS) CONDITIONS FOR TWO PARALLEL HTS CAMPAIGNS (1 IN WORM AND 1 IN FLY). EACH SCREEN WOULD TEST AGAINST 20,000 NOVEL COMPOUNDS TO SEE IMPROVEMENT LARVAL SIZE AS PHENOTYPIC READOUTS. FOUND SPECIFIC COMPOUND IS A ROBUST SUPPRESSOR OF THE LARVAL SIZE DEFECT OF NGLY1-DEFICIENT FLIES AND THAT THE EFFECTS APPEAR CONSISTENT WITH REGULATION BY THE FLY NRF1/2 HOMOLOGS. THIS LATER PIECE IS HELPFUL IN CONFIRMING A CRITICAL PIECE OF BIOLOGY THAT RESEARCHERS HAD HYPOTHESIZED ON RECENTLY. FINALLY, THE TEAM PUBLISHED A MANUSCRIPT SUMMARIZING ALL FINDINGS FROM STAGES 1 AND 2.
IRS990/ProgSrvcAccomActyOtherGrp/Desc1BAYLOR COLLEGE OF MEDICINE - TEAM DUG IN DEEPER ON THE CONNECTION BETWEEN NGLY1 DEFICIENCY AND BMP SIGNALING (A LINK THAT THIS TEAM HAD PUBLISHED ON PREVIOUSLY). THE LAB ALSO DEVELOPED A TEST TO MEASURE A SPECIFIC READ-THROUGH MOLECULE'S ABILITY TO RESCUE THE DISEASE IN FLIES. ONCE BUILT, THE TEAM IDENTIFIED IDEAL DOSAGE. THE TEAM ALSO STUDIED DIFFERENT DIET COMBINATIONS THAT LESSEN THE SEVERITY OF THE DISEASE. THESE FINDINGS COULD LEAD TO SIMPLE CHANGES FOR HUMAN PATIENTS THAT WOULD IMPROVE QUALITY OF LIFE. FINALLY, THE GROUP COLLABORATED WITH A LAB AT STANFORD TO SHOW THAT INCREASING IN SPECIFIC METABOLIC PATHWAY COULD HELP RESCUE PHENOTYPE.
IRS990/ProgSrvcAccomActyOtherGrp/Desc2OTHER PROGRAM SERVICES ARE RELATED TO RESEARCH AND DEVELOPMENT TO UNDERSTAND AND CURE RARE DISEASES BEGINNING WITH NGLY1 DEFICIENCY.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt0106943
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt177671
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt2114963
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt089273
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt160000
IRS990/ProgSrvcAccomActyOtherGrp/GrantAmt297294
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0600124
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0612814
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt0255746
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-269683
IRS990/PYSalariesCompEmpBnftPaidAmt01247
IRS990/PYTotalExpensesAmt0869807
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0600124
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0756593
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt01336131
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt02092724
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0GRACE SCIENCE FOUNDATION WAS FORMED ON MAY 19, 2014. 2017 IS THE FOUNDATION'S FOURTH YEAR OF EXISTENCE.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0PART II AND LINE 13
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01677107
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0600124
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01560381
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0664490
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt04502102
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt02972228
IRS990ScheduleA/SubstantialContributorsTotAmt01529874
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01677107
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0600124
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01560381
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0664490
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt04502102
IRS990ScheduleA/TotalSupportAmt04502102
IRS990/ScheduleBRequiredInd01
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt037500
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0CHECK
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0NGYL1 WORK IN CHARLIE BOONE'S & JASON MOFFAT'S LABS AT UNIVERSITY OF TORONTO
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0CANADA
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt00
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalSpentAmt00
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt090000
IRS990ScheduleI/RecipientTable/CashGrantAmt1350000
IRS990ScheduleI/RecipientTable/CashGrantAmt2100000
IRS990ScheduleI/RecipientTable/CashGrantAmt365000
IRS990ScheduleI/RecipientTable/CashGrantAmt437567
IRS990ScheduleI/RecipientTable/CashGrantAmt516500
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc2501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc3501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc4501(C)(3)
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0ASSAY DEVELOPMENT & COMPOUND SCREENING
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1NGLY1 WORK IN CAROLYN BERTOZZI'S LAB AND LARS STEINMETZ LAB
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2NGLY1 WORK IN GARY RUVKUN'S LAB
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt3NGLY1 WORK IN HAMED JAFAR-NEJAD'S LAB
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt4NGLY1 WORK IN SENTHIL RADHAKRISHNAN'S LAB
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt5FIBROBLAST COLLECTION
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0PERLARA PBC
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1STANFORD UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2MASSACHUSETTS GENERAL HOSPITAL
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt3BAYLOR COLLEGE OF MEDICINE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt4VIRGINIA COMMONWEALTH UNIVERSITY
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt5STANFORD HEALTHCARE
IRS990ScheduleI/RecipientTable/RecipientEIN0941156365
IRS990ScheduleI/RecipientTable/RecipientEIN1041564655
IRS990ScheduleI/RecipientTable/RecipientEIN2741613878
IRS990ScheduleI/RecipientTable/RecipientEIN3546001758
IRS990ScheduleI/RecipientTable/RecipientEIN4946174066
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt06000 SHORELINE CT SUITE 204
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt13145 PORTER DRIVE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt2125 NASHUA STREET SUITE 540
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt31102 BATES AVENUE SUITE 48002
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt4800 E LEIGH ST STE 3200
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt5300 PASTEUR DRIVE MC 5555
IRS990ScheduleI/RecipientTable/USAddress/CityNm0S SAN FRANCISCO
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PALO ALTO
IRS990ScheduleI/RecipientTable/USAddress/CityNm2BOSTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm3HOUSTON
IRS990ScheduleI/RecipientTable/USAddress/CityNm4BOX RICHMOND
IRS990ScheduleI/RecipientTable/USAddress/CityNm5STANFORD
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1CA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2MA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd3TX
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd4VA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd5CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd094080
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd194304
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd202114
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd377030
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd423298
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd594305
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0* BEFORE FUNDING A PRINCIPAL INVESTIGATOR, THE FOUNDATION REQUIRES A DETAILED PROPOSAL WITH OBJECTIVES AND MILESTONES * THE PROPOSALS ARE REVIEWED BY THE FOUNDATION AND SCIENTIFIC ADVISORY BOARD * THE PROPOSALS ARE OFTEN REVISED SEVERAL TIMES TO GET THE CORRECT FIT * ONCE FUNDED, EACH PRINCIPAL INVESTIGATOR SUBMITS A WRITTEN SUMMARY EVERY QUARTER * THIS UPDATE IS TWO TO THREE PAGES IN LENGTH * THE REPORTS DISCUSS PROGRESS, HIGHLIGHT ROADBLOCKS AND IDENTIFY WHERE THEY NEED HELP * THE FOUNDATION STEPS-IN WHERE APPROPRIATE TO MAKE SURE OBJECTIVES AND MILESTONES ARE MET * IN ADDITION TO QUARTERLY REPORTS, THE FOUNDATION HOLDS A MONTHLY CONFERENCE CALL WHERE TWO TO THREE PRINCIPAL INVESTIGATORS PRESENT THEIR LATEST WORK * BEYOND THE ABOVE TWO INITIATIVES, THE FOUNDATION HOLDS ONE TO TWO IN-PERSON MEETINGS PER YEAR * DR. KEVIN LEE (CHIEF SCIENTIFIC OFFICER), DR. SELINA DWIGHT (PROGRAM MANAGER), AND MATT WILSEY(PRESIDENT) CONTACT RESEARCHERS AND PRINCIPAL INVESTIGATORS ON A REGULAR BASIS VIA EMAIL, PHONE, OR ONE ON ONE MEETINGS THE PRESIDENT ENSURES THAT EVERY DOLLAR IS USED TO SUPPORT THE GRACE SCIENCE FOUNDATION'S MISSION.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0PART I, LINE 2:
IRS990ScheduleI/Total501c3OrgCnt05
IRS990ScheduleI/TotalOtherOrgCnt01
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE PRESIDENT OF THE FOUNDATION HAS IMMATERIAL OWNERSHIP INTEREST, IN THE INVESTMENTS OF FORTRESS AND SILVER LAKE, WHICH ARE MANAGED BY TWO OF THE DIRECTORS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE PRESIDENT OF THE FOUNDATION HAS AUTHORITY TO ELECT ONE OR MORE MEMBERS OF THE GOVERNING BODY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2THE FOUNDATION DOES NOT HAVE ANY COMMITTEES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3PRIOR TO FILING FROM 990, THE FOUNDATION'S PRESIDENT WILL REVIEW THE FORM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4NEW BOARD MEMBERS ARE REQUIRED TO COMPLETE A CONFLICTS OF INTEREST POLICY AND SELF REPORT ANY CHANGES THAT MAY PRESENT A CONFLICT.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION A, LINE 8B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART VI, SECTION C, LINE 18
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PART VI, SECTION C, LINE 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TempOrPermanentEndowmentsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt01336131
IRS990/TotalAssetsEOYAmt02109224
IRS990/TotalAssetsGrp/BOYAmt01336131
IRS990/TotalAssetsGrp/EOYAmt02109224
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt01651481
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0117927
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0802587
IRS990/TotalFunctionalExpensesGrp/TotalAmt0920514
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt016500
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt016500
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt01336131
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt02092724
IRS990/TotalOtherCompensationAmt00
IRS990/TotalOtherProgSrvcExpenseAmt0299577
IRS990/TotalOtherProgSrvcGrantAmt0246567
IRS990/TotalProgramServiceExpensesAmt0802587
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt025626
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt01677107
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt05
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt01336131
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt02109224
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TravelGrp/ManagementAndGeneralAmt038
IRS990/TravelGrp/ProgramServicesAmt026352
IRS990/TravelGrp/TotalAmt026390

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$2,109,224
Liabilities
$16,500
Net assets
$2,092,724
Revenue
$1,677,107
Expenses
$920,514
Net income
$756,593
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.22$0.00$2.22$0.94$1.52$0.58
2023Detailed filing. Detailed filing data is available for this year.$2.79$0.04$2.75$0.83$1.29$0.46
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.18$0.05$3.13$1.24$1.22$0.02
2021Detailed filing. Detailed filing data is available for this year.$3.13$0.03$3.10$1.33$1.11$0.21
2020Detailed filing. Detailed filing data is available for this year.$2.88$0.00$2.88$1.45$1.45$0.00
2019Detailed filing. Detailed filing data is available for this year.$2.89$0.00$2.89$1.56$0.84$0.72
2018Detailed filing. Detailed filing data is available for this year.$2.20$0.00$2.20$1.20$1.07$0.13
2017Detailed filing. Detailed filing data is available for this year.$2.11$0.02$2.09$1.68$0.92$0.76
2016Detailed filing. Detailed filing data is available for this year.$1.34$0.00$1.34$0.60$0.87$0.27
2015Summary only. Only limited summary data is available for this year.$1.61$0.00$1.61$1.56$0.56$1.00
2014Detailed filing. Detailed filing data is available for this year.$0.60$0.00$0.60$0.66$0.06$0.60